The Urogenital System Microbiota: Is It a New Gamechanger in Urogenital Cancers?
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(2), P. 315 - 315
Published: Feb. 1, 2025
The
human
microbiome,
which
encompasses
microbial
communities
and
their
genetic
material,
significantly
influences
health
disease,
including
cancer.
urogenital
microbiota,
naturally
present
in
the
urinary
genital
tracts,
interact
with
factors
such
as
age,
lifestyle,
conditions
to
affect
homeostasis
carcinogenesis.
Studies
suggest
that
alterations
this
microbiota
contribute
development
progression
of
genitourinary
cancers,
emphasizing
concept
oncobiome,
refers
contributions
Similarly,
gut
can
influence
hormone
levels
systemic
inflammation,
impacting
cancers
cervical
prostate
Advanced
studies
indicate
have
distinct
profiles
may
serve
diagnostic
biomarkers
or
therapeutic
targets.
Dysbiosis
correlates
bladder
kidney
Additionally,
effectiveness
cancer
treatments.
However,
further
research
is
necessary
clarify
causality,
role
metabolites,
hormonal
regulation.
aim
review
understand
these
dynamics
opportunities
for
innovative
diagnostics
therapies,
highlighting
need
integration
microbiology,
oncology,
genomics
explore
cancers.
For
this,
a
comprehensive
search
relevant
databases
was
conducted,
applying
specific
inclusion
exclusion
criteria
identify
examining
association
between
Research
into
mechanisms
by
pave
way
new
approaches,
ultimately
improving
patient
outcomes.
Language: Английский
Association of Gestational Diabetes Mellitus with Multi Drug Resistant Vaginal Infections among Pregnant Women
Nauman Tariq,
No information about this author
Maryam Iqbal,
No information about this author
Mehwish Sheraz
No information about this author
et al.
Indus journal of bioscience research.,
Journal Year:
2025,
Volume and Issue:
3(2), P. 245 - 252
Published: Feb. 25, 2025
Background:
Vaginal
infections
caused
by
various
pathogenic
microorganisms,
along
with
the
emergence
of
antibiotic
resistance,
pose
significant
medical
challenges.
Gestational
diabetes
mellitus
(GDM)
is
a
critical
factor
that
can
delay
recovery
from
and
lead
to
complications.
Methodology:
This
study
was
conducted
as
cross-sectional
analysis
involving
pregnant
women.
A
total
120
vaginal
swabs
were
collected
participants
analyzed
identify
microorganisms
present
assess
their
susceptibility.
The
subjects
categorized
into
two
groups
based
on
diabetic
status:
those
GDM
without.
Various
biochemical
tests,
culturing
methods,
sensitivity
patterns
performed
high
swab
isolates.
Results:
revealed
56%
women
studied
aged
between
23
37
years,
67%
in
third
trimester.
Among
identified,
Candida
species
accounted
for
51%,
while
gram-positive
bacteria
comprised
24.3%
gram-negative
25.19%.
Within
category,
Methicillin-resistant
Staphylococcus
aureus
(MRSA)
most
prevalent
at
30.25%,
followed
Enterococcus
faecalis
15%
Streptococcus
3.11%.
For
bacteria,
Klebsiella
pneumoniae
found
44.4%
cases,
E.
coli
31.3%,
Pseudomonas
aeruginosa
14.1%,
stutzeri
6.05%,
Acinetobacter
baumannii
3.02%.
Susceptibility
testing
indicated
primarily
sensitive
Linezolid
but
resistant
azithromycin,
vancomycin
cotrimoxazole
effective
against
MRSA,
cloxacillin
showing
resistance.
Vancomycin
also
treatment
faecalis,
whereas
azithromycin
exhibited
resistance
levels.
Gentamicin
coli,
Rofloxacin
showed
highest
resistance;
Imipenem
P.
aeruginosa,
Amikacin
association
multidrug-resistant
(MDR)
GDM.
Conclusion:
concluded
there
no
MDR
gestational
among
Language: Английский
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(5), P. 2492 - 2492
Published: Feb. 20, 2024
A
healthy
vaginal
microbiota
hosts
Lactobacillus
as
the
most
predominant
genus.
Lactobacilli
play
a
role
in
human
health
through
production
of
diverse
antimicrobial
substances
that
can
act
against
pathogens
or
modulate
immune
system.
Previous
reports
highlighted
ability
lactobacilli
to
counteract
viruses
causing
STIs,
e.g.,
HIV-1
and
HSV-2.
In
this
report,
we
analyze
activity
supernatants
HSV-1
infection,
which
is
becoming
increasingly
relevant
STI.
We
show
two
species
(i.e.,
L.
crispatus
gasseri)
were
active
at
neutralizing
infection
different
cell
lines
simian
origin.
Specifically,
demonstrate
strains
are
effective
antiviral
activity,
evidenced
by
comparison
with
pathogen
taken
reference.
The
effect
was
specific
not
attributable
generic
toxicity
cells.
Our
results
pave
way
for
development
probiotics
limit
impact
on
women’s
health.
Language: Английский
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections
Elisa Avitabile,
No information about this author
Laura Menotti,
No information about this author
Vanessa Croatti
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(17), P. 9168 - 9168
Published: Aug. 23, 2024
The
healthy
cervicovaginal
microbiota
is
dominated
by
various
Lactobacillus
species,
which
support
a
condition
of
eubiosis.
Among
their
many
functions,
vaginal
lactobacilli
contribute
to
the
maintenance
an
acidic
pH,
produce
antimicrobial
compounds,
and
modulate
host
immune
response
protect
against
bacterial
fungal
infections.
Increasing
evidence
suggests
that
these
beneficial
bacteria
may
also
confer
protection
sexually
transmitted
infections
(STIs)
caused
viruses
such
as
human
papillomavirus
(HPV),
immunodeficiency
virus
(HIV)
herpes
simplex
(HSV).
Viral
STIs
pose
substantial
public
health
burden
globally,
causing
range
infectious
diseases
with
potentially
severe
consequences.
Understanding
molecular
mechanisms
exert
protective
effects
viral
paramount
for
development
novel
preventive
therapeutic
strategies.
This
review
aims
provide
more
recent
insights
into
intricate
interactions
between
STIs,
exploring
impact
on
microenvironment,
response,
infectivity
pathogenesis,
highlighting
potential
implications
interventions
clinical
management
Language: Английский
A gender perspective on diet, microbiome, and sex hormone interplay in cardiovascular disease
Acta Physiologica,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 12, 2024
Abstract
A
unique
interplay
between
body
and
environment
embeds
reflects
host–microbiome
interactions
that
contribute
to
sex‐differential
disease
susceptibility,
symptomatology,
treatment
outcomes.
These
differences
derive
from
individual
biological
factors,
such
as
sex
hormone
action,
sex‐divergent
immune
processes,
X‐linked
gene
dosage
effects,
epigenetics,
well
their
interaction
across
the
lifespan.
The
gut
microbiome
is
increasingly
recognized
a
moderator
of
several
systems
are
thus
impacted
by
its
function
composition.
In
humans,
components
further
interact
with
gender‐specific
exposures
dietary
preferences,
stressors,
life
experiences
form
complex
whole,
requiring
innovative
methodologies
disentangle.
Here,
we
summarize
current
knowledge
among
hormones,
microbiota,
system,
vascular
health
relevance
for
epidemiology
cardiovascular
diseases.
We
outline
clinical
implications,
identify
gaps,
place
emphasis
on
required
future
studies
address
these
gaps.
addition,
provide
an
overview
caveats
associated
conducting
research
require
consideration
sex/gender
differences.
While
previous
work
has
inspected
separately,
here
call
attention
translational
utility
combined
perspective
research,
gender
medicine,
biology.
Language: Английский
An updated study of the relationship between bacterial infections and women's immune system, focusing on bacterial compositions with successful pregnancy
Raed Obaid Saleh,
No information about this author
Omar Dheyauldeen Salahdin,
No information about this author
Irfan Ahmad
No information about this author
et al.
Journal of Reproductive Immunology,
Journal Year:
2024,
Volume and Issue:
165, P. 104283 - 104283
Published: June 25, 2024
Language: Английский
Understanding vaginal biofilms: The first step in harnessing antimicrobial nanomedicine
Journal of Controlled Release,
Journal Year:
2024,
Volume and Issue:
376, P. 1190 - 1208
Published: Nov. 12, 2024
In
spite
of
multipurpose
technologies
offering
broad-spectrum
prevention
for
sexually
transmitted
infections
(STIs)
and
contraception,
the
STIs
incidences
rise
worldwide.
The
situation
is
even
more
alarming
considering
continuous
in
antimicrobial
resistance
(AMR)
that
limits
therapy
options.
this
review
we
address
specific
challenges
efficiently
treating
vaginal
locally,
at
infection
site,
by
understanding
underlying
barriers
to
efficient
treatment
such
as
biofilms.
Knowledge
on
biofilms
remains,
up
now,
rather
scarce
requires
attention.
We
therefore
propose
a
'back
basics'
insight
seeks
probe
complexity
role
microbiota,
its
relationship
with
implications
future
therapeutic
modalities
utilizing
advanced
nano
delivery
systems.
Our
key
objective
highlight
interplay
between
biofilm,
(nano)formulation
outcome
than
provide
an
overview
all
nanoformulations
were
challenged
against
focused
anatomy
female
reproductive
organ
physiological
changes
from
birth,
unique
microenvironment
premenopausal
postmenopausal
women,
biofilm
current
nanomedicine-based
approaches
treat
site.
Finally,
offer
our
perspectives
associated
considerations
can
aid
design
development
safer
potent
products
persisting
infections.
Language: Английский
Recent advances in in vitro models simulating the female genital tract toward more effective intravaginal therapeutic delivery
Expert Opinion on Drug Delivery,
Journal Year:
2024,
Volume and Issue:
21(7), P. 1007 - 1027
Published: July 2, 2024
Intravaginal
drug
delivery
has
emerged
as
a
promising
avenue
for
treating
spectrum
of
systemic
and
local
female
genital
tract
(FGT)
conditions,
using
biomaterials
carriers
or
scaffolds
targeted
efficient
administration.
Much
effort
been
made
to
understand
the
natural
barriers
this
route
improve
system
achieve
an
therapeutic
response.
Language: Английский
Evaluation of the Effects of Age, Sex, and Dexpanthenol-Containing Skin Care on the Facial and Body Skin Microbiome
Zainab Qaizar,
No information about this author
Raffaella de Salvo,
No information about this author
Gregor Bieri
No information about this author
et al.
Cosmetics,
Journal Year:
2024,
Volume and Issue:
11(6), P. 213 - 213
Published: Dec. 6, 2024
Given
the
pivotal
role
played
by
microbiome
in
skin
health,
it
is
important
to
understand
how
its
composition
varies
with
age,
sex,
and
body
site
regular
use
of
topical
products.
Four
studies
were
carried
out
determine
effects
long-term
(4-week)
different
dexpanthenol-containing
products
on
a
varied
population
cosmetically
dry
skin.
The
was
assessed
before
after
product
usage.
No
significant
changes
richness
or
diversity
found
for
individual
test
products;
however,
meta-analysis
combined
dataset
did
show
as
function
subject’s
site.
work
presented
here
demonstrates
carefully
formulated
skin,
when
used
way
that
representative
real-life
usage
conditions,
can
respect
microbial
present
across
widely
study
population.
Language: Английский